PillsBloomberg Business released an article on the pending partnership between Sanofi and Regeneron Pharmaceuticals in their mission to fun cancer therapies.  “Sanofi agreed to contribute $2.2 billion to work with Regeneron Pharmaceuticals Inc. on therapies that harness the immune system to fight cancer.”  For more information, please visit: http://www.bloomberg.com/news/articles/2015-07-28/sanofi-joins-regeneron-in-2-2-billion-pact-for-cancer-therapies